Preformulation studies on Imexon

被引:11
|
作者
Kuehl, PJ [1 ]
Hoye, WL [1 ]
Myrdal, PB [1 ]
机构
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
关键词
Imexon; preformulation studies; general acid/base catalysis; pH stability; solubility;
D O I
10.1080/03639040600599830
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Imexon is an aziridine containing iminopyrrolidone that, through aziridine ring opening, is able to induce oxidative stress resulting in apoptosis. The main objective of this research was to conduct extensive preformulation studies on Imexon in order to understand the factors that affect its stability. The results obtained indicate that the stability of Imexon is dependant on pH, ionic strength, temperature, buffer species, and initial concentration. Degradation of Imexon follows apparent first-order degradation kinetics with the primary degradation product resulting from opening of the aziridine ring. In order to maximize stability, ionic strength, temperature, and initial concentration should be minimized, with an optimal range pH between 7.2 and 9.0. Experimentation with other aqueous solutions indicates that Imexon has increased stability in D5W as opposed to normal saline, while it undergoes rapid degradation in 6% H2O2. Imexon is not ionizable between pH 5.0 to 8.5 and has an aqueous solubility of approximately 25 mg/mL over this range. Solid-state characterization has concluded that Imexon is a crystalline solid that begins decomposition at 165 degrees C, prior to melting.
引用
收藏
页码:687 / 697
页数:11
相关论文
共 50 条
  • [1] Preformulation studies of levonorgestrel
    Ridichie, Amalia
    Ledeti, Adriana
    Sbarcea, Laura
    Rusu, Gerlinde
    Muntean, Cornelia
    Circioban, Denisa
    Peter, Francisc
    Ledeti, Ionut
    [J]. JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2024,
  • [2] Preformulation Studies on Piperlongumine
    Aodah, Alhassan
    Pavlik, Aaron
    Karlage, Kelly
    Myrdal, Paul B.
    [J]. PLOS ONE, 2016, 11 (03):
  • [3] AN OVERVIEW ON PREFORMULATION STUDIES
    Desu, Prasanna Kumar
    Vaishnavi, G.
    Divya, K.
    Lakshmi, U.
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 2 (10): : 1399 - 1407
  • [4] Polymorphism and preformulation studies of lifibrol
    Burger, A
    Lettenbichler, A
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (01) : 65 - 72
  • [5] Expediting Early Preformulation Studies
    Middaugh, C. Russell
    [J]. GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2012, 32 (15): : 42 - 43
  • [6] PREFORMULATION STUDIES FOR A PARENTERAL SOLUTION OF MEMANTINE
    Achim, Marcela
    Vlase, Laurian
    Tomuta, Ioan
    Muntean, Dana
    Iuga, Cristina
    Georgescu, Radu
    Leucuta, Sorin
    [J]. FARMACIA, 2011, 59 (05) : 636 - 646
  • [7] Transdermal delivery of phenobarbital Preformulation studies
    Odri, S.
    Stupar, M.
    Eros, I.
    Antal, I.
    Klebovich, I.
    Szabo-Revesz, P.
    Csanyi, E.
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2008, 18 (06) : 417 - 423
  • [8] PREFORMULATION STUDIES ON NAPROXEN SODIUM SUPPOSITORIES
    SANTUS, G
    GIORDANO, F
    GAZZANIGA, A
    BRUNI, G
    PAIOTTI, S
    YAN, JX
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1994, 40 (04) : 243 - 245
  • [9] Preformulation Studies on Palonosetron Hydrochloride Injection
    Ramya, S.
    Bose, P. S. C.
    Nagaraju, R.
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 71 (02) : 165 - 165
  • [10] What is the real existing form of imexon? Quantum chemical studies
    Kheffache, D.
    Ouamerali, O.
    [J]. JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2010, 945 (1-3): : 39 - 44